Characterization of MK-329
- 1 January 1991
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A new potent and selective non-peptide gastrin antagonist and brain cholecystokinin receptor (CCK-B) ligand: L-365,260European Journal of Pharmacology, 1989
- MK-329Drugs of the Future, 1989
- Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260Journal of Medicinal Chemistry, 1989
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsJournal of Medicinal Chemistry, 1988
- Synthesis and resolution of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-onesThe Journal of Organic Chemistry, 1987
- Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsJournal of Medicinal Chemistry, 1987
- Crystallization-induced asymmetric transformation: stereospecific synthesis of a potent peripheral CCK antagonistThe Journal of Organic Chemistry, 1987
- Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.Proceedings of the National Academy of Sciences, 1986
- Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.Proceedings of the National Academy of Sciences, 1986
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985